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ABSTRACT: Naturally occurring glycoconjugates possess carbohydrate moieties that fulﬁll essential roles in many biological
functions. Through conjugation of carbohydrates to therapeutics or imaging agents, naturally occurring glycoconjugates are
mimicked and eﬃcient targeting or increased cellular uptake of glycoconjugated macromolecules is achieved. In this work, linear
and cyclic glucose moieties were functionalized with methacrylates via enzymatic synthesis and used as building blocks for
intramolecular cross-linked single-chain glycopolymer nanoparticles (glyco-SCNPs). A set of water-soluble sub-10 nm-sized
glyco-SCNPs was prepared by thiol-Michael addition cross-linking in water. Bioactivity of various glucose-conjugated
glycopolymers and glyco-SCNPs was evaluated in binding studies with the glucose-speciﬁc lectin Concanavalin A and by
comparing their cellular uptake eﬃciency in HeLa cells. Cytotoxicity studies did not reveal discernible cytotoxic eﬀects, making
these SCNPs promising candidates for ligand-based targeted imaging and drug delivery.
Biological functions of carbohydrates range widely fromhighly speciﬁc cellular recognition and communication, to
the supply of energy.1,2 Carbohydrate transport through the
cell membrane is facilitated by speciﬁc membrane-bound
carbohydrate transporters, that is, GLUT 1−14, which have
therefore become popular targets for cell targeting with
nanomaterials.3,4 Furthermore, bacteria and viruses exhibit
surfaces covered with carbohydrate-binding proteins, that is,
lectins, with high binding aﬃnity toward carbohydrates
displayed on the targeted (human) cells.5,6 This mimicry
hinders recognition by the immune system and clearance of
bacteria and viruses. Hence, functionalization of (polymer)
nanomaterials with carbohydrates is a popular strategy to avoid
immune response and furthermore may introduce targeting
capabilities and increase cellular uptake.4,7−12 For example,
glucose-modiﬁed micelles were recently found to be taken up
to an increased extent by cells with overexpressed GLUT 1
receptors and to cross the blood−brain barrier in fasting
mice.11 For successful brain uptake, glycaemic control of the
mice diet and conjugation on the C6 position instead of the C3
position proved crucial, which suggests a transporter-mediated
uptake mechanism. For the interaction between glucose and
the transporter, mainly the C1−C3 hydroxyl groups are
assumed to play a role.13 Similarly, substitution of galactose
either on C1 or C6 position was inﬂuential for the endocytic
pathway of conjugated nanoparticles.14
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To obtain glycopolymers and -nanoparticles, carbohydrate
functionalities can either be attached postpolymerization or
employed in the form of glycomonomers.15−17 Controlled
polymerization techniques, such as via reversible addition−
fragmentation chain transfer (RAFT), oﬀer superior structural
control in both strategies. In case of postpolymerization
functionalization, full substitution is impeded by steric
hindrance and multistep protective group chemistry is typically
required. Alternatively, glycomonomers are obtained via
protective group chemistry or via enzymatic pathways
providing chemo-, regio-, and stereoselectivity.16−18
The carbohydrate recognition eﬃcacy of transporters
depends on the architecture of the glycomacromolecule and
varies with the carbohydrate hydroxyl group substitutions and
carbohydrate linker density and spacing.3,10,19,20 Not only in
nature, but also synthetically, a variety of glycomacromolecule
topologies is known, ranging from dendrimers to nano-
gels.17,21−23 Multivalency in such structures is a striking factor
to achieve selective binding toward the target site.2,24,25 One
way to evaluate the selective recognition of glycomacromole-
cules is to test their binding aﬃnity to lectins. Concanavalin A
(ConA) from Canavalia ensiformis (Jack bean) is one of the
most studied lectins for modeling receptor interactions of
glycomacromolecules, as it is structurally similar to a large
number of bacterial and animal lectins in cell communication
events.25−27 Dendritic structures and micelles have shown
superior binding as compared to linear polymer chains, as
evaluated through ConA binding assays.28−30 Whereas the
complexity of the well-deﬁned dendrimers increases with every
generation, polymeric structures oﬀer ease of synthesis, to
certain extents at the cost of loss in structural control.
Single-chain polymer nanoparticles (SCNP) are prepared
through exclusive intramolecular cross-linking of polymer
chains and typically measure around 10 nm in diameter.31−36
SCNPs are comparable in size to dendrimers, while the
combination of polymer preparation techniques greatly
alleviates synthetic eﬀort. Recently, SCNPs have also been
prepared from glycopolymers,37−39 and current investigations
are focused on controlling the structures of SCNPs and their
biomedical applications.40−44 Loinaz and co-workers have
investigated SCNPs prepared from acrylate-functional dextran
as a noninvasive drug delivery system targeted to the lungs,
taking advantage of the small sizes of SCNPs. Further, Fulton
and co-workers demonstrated that glyco-SCNPs from
galactose or mannose conjugated polymers display speciﬁc
molecular recognition by surfaces coated with ConA or with E.
coli heat labile toxin.38 Glyco-SCNPs prepared directly from
polymerized acetylated-mannose monomers were developed
by Barner-Kowollik and co-workers via cross-linking by UV
irradiated tetrazole cycloaddition under ultrahigh dilution for
subsequent cellular uptake experiments.39 More recently, Becer
and co-workers investigated lectin binding of SCNPs based on
a cyclodextrin/adamantane-folded ABC triblock copolymer
with a mannose acrylamide middle block.45 Folding into
SCNPs resulted in increased lectin binding in comparison to
their linear precursors.
We previously demonstrated the drug encapsulation
potential of water-soluble SCNPs, both in aqueous and organic
medium.46 Here, we report the development of analogous
glucose-functional SCNPs and evaluation of their cell-targeting
properties. Well-deﬁned SCNPs were prepared, based on three
diﬀerent glucose-monomers, conjugated at the C1 or C6
glucose positions, and their in vitro cell targeting behavior was
evaluated in relation to the mode of glucose functionalization.
Precursor copolymers were prepared from enzymatically
synthesized C1- and C6-functionalized glucose monomers
and the corresponding SCNPs were subsequently obtained via
thiol-Michael cross-linking of the precursor glycopolymers
(Scheme 1). Bioactivities of the resulting SCNPs were
compared based on their lectin binding abilities, reductive
properties, cell toxicity, and uptake by HeLa cells.
Glucose-based molecules were conjugated with methacrylate
moieties via enzymatic coupling reactions based on literature
procedures. Bead immobilized lipase from Candida antarctica
catalyzed the conjugation at the C6 position as established by
Davis and co-workers,47 whereas β-glucosidase from almonds
was used for C1 conjugation as described by the Loos group.18
Conjugation at the C1 position blocks the opening of glucose
to its linear form and due to the enzymatic reaction, only the β-
anomer is formed G1MA (M3), as conﬁrmed by the absence of
the H1-α signal in 1H NMR spectroscopy. C6 conjugation was
performed on methyl glucoside resulting in the formation of
the mG6MA monomer (M1), where the glucose is ﬁxed in its
α-ring pyranose form, as well as on glucose, resulting in the
formation of the G6MA monomer (M2), where the molecule
can still interconvert between its open-chain form and the α/β
anomers after conjugation. The thiol-functional monomer,
xanthate methacrylate (XMA), was prepared following
established literature procedures and combined via RAFT
copolymerization with the glucose monomers.48,49 Aliquots of
the polymerizations were taken at regular intervals to conﬁrm
equal consumption of the monomers and hence to conﬁrm a
random copolymerization. Copolymers P1−P3, prepared from
monomers M1−M3, were obtained with molecular weights of
40 kDa (P1a) and 100 kDa (P1b−P3) and with typical
xanthate incorporation ratios of 15−20% (Table 1). Low
dispersity indices (PDI) were achieved for the polymers (Đ ∼
1.2), except for P2 (Đ = 1.5), as analyzed by gel permeation
chromatography (GPC), which may suggest interaction
between M2 and the chain transfer agent (CTA).
SCNP formation from glucose-containing precursor poly-
mers was based on a protocol that we developed previously for
glycerol-xanthate copolymers.46 After deprotection of the
xanthate moiety with hydrazine, as observed with 1H NMR
spectroscopy (Figure S3), the obtained thiol polymers were
Scheme 1. Schematic Representation of Glyco-SCNPs by
Thiol-Michael Addition
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slowly added to a carbonate buﬀered solution containing PEG
diacrylate and tris(2-carboxyethyl)phosphine. Dimethylami-
noethyl acrylate was added toward the end of the reaction to
functionalize any remaining unreacted thiols. 1H NMR
measurements conﬁrmed successful thiol-Michael addition by
additional signals between 2.8 and 3.0 ppm (Figures S4−S7).
To observe the chain collapse caused by intramolecular
cross-linking, GPC measurements were performed, which
revealed an apparent size reduction of around 30% (Table 1
and Figure 1). Moreover, multiangle light scattering (MALS)
conﬁrmed constant molecular weights for NP1b and NP3, as
compared to their precursor polymers P1b and P3 (Figure
S9).
Furthermore, intrinsic viscosities [η] were reduced after
cross-linking, which is related to a reduced hydrodynamic
radius and hence to intramolecular cross-linking. Plotting
diﬀerential weight fraction against molar mass does not
indicate increases in molar mass upon cross-linking, therefore
excluding multichain-aggregates and thus pointing to exclusive
intramolecular cross-linking. However, NP2 displayed an
increased Mn, indicating formation of intermolecular cross-
links. Diﬀerential molar mass weight fractions of NP2
conﬁrmed the coexistence of multichain aggregates of NP2
with higher Mn than the original polymer. The formation of
multichain aggregates precludes a reduction of [η], but the
diﬀerential intrinsic viscosity weight fraction does reveal
presence majority of fractions with reduced [η]. Despite the
presence of intermolecular cross-links (<20%, Figure S9),
intramolecular cross-linking is predominant.
For polymers P1a, P2, and P3 (Mn ≥ 90 kDa), size
reductions were observed in dynamic light scattering (DLS)
upon SCNP formation (Table 1 and Figure S8). In the case of
the shortest precursor polymer (P1b, 40 kDa), a reduction in
size was not detectable with DLS. However, additional
measurements with diﬀusion-ordered spectroscopy (DOSY)
NMR on P1a and NP1a revealed a slight particle size
reduction from 3.9 to 3.7 nm. Furthermore, transmission
electron microscopy (TEM) on negatively stained NP1a
revealed particles of around 5 nm in radius with a uniform
particle shape and size (Figure S10).
The reducing characteristics of the glucose monomeric units
in the prepared polymers and SCNPs were evaluated with
Benedict’s reagent (Figure 2), a citrate solution that complex-
ates copper(II), resulting in a blue color.50 Formation of red
copper precipitates in Benedict’s solution with P2 and NP2
conﬁrms preservation of reducing properties of the glucose
monomeric units. Hence, ring-opening of glucose in M2 is not
blocked by polymerization or cross-linking. For the other
polymers and nanoparticles, no color change was expected as
the glucosides are present in the pyranose, nonreducing form.
Surprisingly, polymers P1 and P3 result in green colors when
performing the reduction assay, while the NP1 and NP3
solutions stayed blue as the negative control. Diethyldithio-
carbamates, comparable to the CTA- and xanthate moieties on
polymers P1 and P3, have been reported earlier to form
copper complexes with CuCl2, resulting in color changes from
green to brown.51 As controls, the RAFT homopolymers
pHEMA and a glycerol methacrylate-co-XMA copolymer were
tested with Benedict’s reagent. Whereas pHEMA did not result




c (kg/mol) χSH Đ
b ΔMappe (%) rH,DLSf (nm) rH,DOSYf (nm) rH,viscod (nm) [η]d (mL/g)
P1a 40 32 14 1.13 3.4 3.9
Np1a 22 1.16 30 3.4 3.7
P1b 108 154 102 17 1.31 6.4 9.4 33.4
Np1b 101 91 1.13 34 2.8 8.0 26.8
P2 105 89 70 15 1.45 5.9 7.8 23.6
NP2 63 87 1.46 30 3.2 12.4 28.1
P3 102 105 83 20 1.23 5.7 8.8 27.2
NP3 80 65 1.10 24 1.9 6.2 19.4
aDetermined by 1H NMR. bDetermined in DMF by GPC, relative to PEG standards. cDetermined in DMF by GPC, by MALS measurements.
dDetermined in DMF by GPC, by a viscometer. eReduction in apparent number-average molecular weight, calculated as ΔMapp = −((Mn,NP −
Mn,P)/Mn,NP) × 100%.
fMeasured in H2O/D2O.
Figure 1. Overlay of GPC traces for the glycocopolymer precursors
(P1−3) with diﬀerent chain lengths and their corresponding
nanoparticles (NP1−3).
Figure 2. Bendicts assay with glycopolymers (P1−3) and
corresponding nanoparticles (NP1−3) (sucrose = negative control,
glucose = positive control, pHEMA = polymer with same CTA,
pXMA = copolymer containing XMA).
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in a color change, the XMA copolymer revealed a similar color
shift as polymers P1 and P3. Presumably, the color change is
therefore due to copper interactions with the xanthate moieties
and is not caused by the glucose functionalities. Neither
monomer synthesis, nor polymerization or SCNP formation,
aﬀected the nonreducing and reducing properties of the
glucoside and glucose monomeric units, respectively.
ConA is a lectin with four binding sites at pH 7, which are
speciﬁcally sensitive to glucose moieties.25,27 Various carbohy-
drate conjugated positional isomers have been thoroughly
investigated, demonstrating speciﬁcity of ConA toward α-
glucose over β-glucose, while substitution of hydroxyl groups
at the 3-, 4-, and 6-carbon positions has shown to disrupt
carbohydrate recognition.52 Therefore, the binding ability of
C1- and C6-functionalized glucose repeating units in polymers
P1−P3 and nanoparticles NP1−NP3 was tested in a
quantitative ConA precipitation assay. In agreement with
literature reports, polymers with glycomonomers function-
alized at the C6 position (P1 and P2), and the corresponding
SCNPs (NP1 and NP2) showed a lower binding aﬃnity
toward ConA.52 Interestingly, ConA did not even precipitate
when exposed to P2 or NP2 and precipitation was inhibited,
comparable to monomeric glucose. In contrast, P3 and NP3
with C1-functionalized glucose in its β-conﬁguration were
indeed recognized by ConA, where NP3 displayed a
signiﬁcantly decreased binding aﬃnity toward ConA as
compared to its linear precursor P3 (Figure S11). P3/NP3
not only contain a C1-conjugated glucose, but also a longer
linker (one methylene unit) between glucose moiety and
acrylate group than in the case of P1/NP1 and P2/NP2, which
might enhance ConA recognition. Since the SCNP is no longer
linear, but rather collapsed and cross-linked, the glucose
moieties are likely less available for formation of clusters with
lectins. The decreased lectin binding upon SCNP formation is
in contrast with the ﬁndings of Becer and co-workers with C-
shaped mannose SCNPs, where the mannose units are
incorporated in the middle segment of the polymer, and only
the end blocks are cross-linked.45 The diﬀerence between the
studies highlights the importance of the secondary structure of
glycomacromolecules on molecular recognition. Here, the
ConA binding studies conﬁrm the positional dependency of
glucose functionalization on molecular recognition and point
toward reduced ﬂexibility of the polymer chain after cross-
linking. However, interaction of glycomacromolecules with a
single lectin is not representative for the wide range of
interactions between cell receptors, proteins, and transporters.
In order to further evaluate the eﬀects of the positional isomers
of glycoconjugates, in vitro studies were performed with each
conjugate.
HeLa cells express predominantly GLUT1 and GLUT3 as
glucose transporters and were therefore selected for our
investigations.53 Cytotoxicity of the diﬀerent SCNPs was
evaluated at concentrations up to 200 μg/mL. None of the
polymers or SCNPs displayed signiﬁcant toxicity, even at the
highest concentrations, after 24 or 48 h and likewise no
concentration dependency could be discerned (Figure S12).
Additional evaluation of P1 and NP1 on human endothelial
brain cells (hCMEC/D3) also did not reveal notable eﬀects on
cell viability.
In order to facilitate cell uptake studies, particles were
ﬂuorescently labeled with 5-(4,6-dichlorotriazinyl)-
aminoﬂuorescein (DTAF), which was conﬁrmed by GPC
equipped with ﬂuorescence detector. As free label was still
detectable after extensive dialysis, the samples were puriﬁed by
FPLC prior to cell experiments. NP1−3 were incubated with
HeLa cells and FACS experiments were conducted at diﬀerent
incubation time points to quantify nanoparticle uptake (Figure
3). For all nanoparticles, cellular uptake was conﬁrmed and
increased with incubation time. Highest uptake was observed
for NP2, comprising glucose with a free C1 position. Lowest
uptake was clearly observed for NP3, with glucose moieties
conjugated at the C1 position. NP1, which is composed of C6-
conjugated glucose with a modiﬁed C1 position, is taken up to
an intermediate amount.
To further investigate the uptake mechanism, the nano-
particle uptake to HeLa cells was studied in combination with
confocal microscopy. In agreement with the FACS results, all
three nanoparticles NP1−3 were observed inside of the cells,
while the ﬂuorescence intensity is substantially reduced in the
case of NP3. As the confocal images show clear vesiculation of
the nanoparticles, early endosomes, late endosomes, and
lysosomes were stained in addition to the nucleus and
membrane (Figures 4 and S14−17). After 4 h of incubation,
ﬂuorescence of the SCNPs only partially overlapped with early
endosomes, but strong colocalization with the late endosome
and lysosome staining was observed for all nanoparticles.
Furthermore, the intensity of the endosome and lysosome
staining is strongly increased in the case of NP1 and NP2
incubation in contrast to the control cells.
In combination with the diﬀering cellular uptake for the
three glyco-SCNPs, these results strongly suggest receptor-
mediated uptake to the HeLa cells. For cellular recognition, the
C1 position of the glucose hydroxyl groups is more relevant
than the C6 position. However, methylation of the C1
hydroxyl does not impede uptake drastically, which supports
that not one single hydroxyl group is solely responsible for
recognition.11,13 Further, the similar cellular uptake behavior of
NP1 and NP2 also implies that the linear structure of glucose
is not essential for recognition and that the pyranose form
participates in receptor binding.
In this work, we describe the synthesis and incorporation of
C1- and C6-glucose-derived methacrylates into RAFT
copolymers and into SCNPs. Furthermore, the resulting
nanoparticles were compared with regards to molecular
recognition and targeting behavior. The reductive properties
of the C6-glucose moiety were preserved upon RAFT
copolymerization, as well as cross-linking via thiol-Michael
addition and are, hence, expected to be also accessible in
cellular environments. Evaluation of the glyco-SCNPs in ConA
binding assays revealed strongest binding when the C6
position of glucose remains accessible. While all three glyco-
Figure 3. FACS analysis of uptake of glyco-SCNP (NP1−3) to HeLa
cells: (a) Histogram after 8 h of incubation; (b) Uptake index (UI)
over time (UI = mean ﬂuorescence intensity (MFI) of treated cells/
MFI of control cells).
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SCNPs were taken up via the endocytic pathway, the eﬃciency
of their uptake to HeLa cells diﬀered. Comparison of the
cellular uptake eﬃciency of SCNPs with glucose moieties
conjugated through the C1 and C6 position, in their blocked
pyranose and in their partly linear form, demonstrates that the
eﬀect of a reducing glucose is minor in comparison to the
position of conjugation. Accordingly, equipping SCNPs with
glycoligands provides control over cell targeting, which may be
exploited in tumor targeting.
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